Glutathione, Myer’s Cocktail, or Tri-Immune Boost Anaphylactic Shock and Death Lawsuit Lawyers

Centric Compounding Injectable Drug Recall Lawsuit: Glutathione, Myer’s Cocktail And Tri-Immune Boost Endotoxin Injury Claims.

What Parker Waichman LLP Found

• Six lots of three Centric Compounding injectable products are included in the nationwide recall.
• The FDA-posted recall states that elevated endotoxin exposure could cause serious reactions including hypotension, inflammatory reactions, anaphylactic shock, and death.
• Centric Compounding reported nine adverse reaction reports associated with the recalled products.
• The FDA separately reported at least 30 patients experiencing adverse events following administration of IV glutathione alone or with other ingredients in a broader 2026 glutathione safety issue.
• People injured after receiving a recalled injection should consider preserving the vial, packaging, lot information, medical records, bills, and documentation showing when and where the injection was obtained.

A nationwide recall involving compounded injectable medications has raised serious concerns for patients who received Glutathione, Myer’s Cocktail, or Tri-Immune Boost products supplied by Centric Compounding LLC. The U.S. Food and Drug Administration posted the recall after certain injectable products were found to have been compounded using a Glutathione active pharmaceutical ingredient, or API, containing elevated endotoxin levels. According to the recall announcement, exposure to elevated endotoxin levels through an injectable product creates a reasonable probability of significant medical events, including fever, hypotension, inflammatory reactions, anaphylactic shock, and death. Centric Compounding reported receiving nine reports involving symptoms including fever, chills, chest pain, nausea or vomiting, headache, and malaise. The affected products were distributed nationwide directly to patients through home delivery as well as to healthcare prescribers.

For patients who became sick after receiving one of these injections, the recall may raise questions extending well beyond obtaining a replacement vial. A serious reaction can lead to emergency treatment, hospitalization, diagnostic testing, lost income, continuing medical problems, and substantial financial losses. Depending on the facts, an injured patient may have grounds to investigate whether a product liability, negligence, pharmaceutical injury, or other civil claim can be brought against one or more entities involved in producing, compounding, supplying, or distributing the product.

Which Centric Compounding Products Have Been Recalled?

The recall applies specifically to six lots of Glutathione 200 mg/mL, Myer’s Cocktail, and Tri-Immune Boost injectable products packaged in 30 mL multidose vials. According to the FDA-posted company announcement, the products were distributed nationwide to patients through home delivery and to prescribers.

The affected products are:

The recall notice states that these products were used to support immunity, fatigue, and general wellness. Centric Compounding is contacting distributors and customers and arranging replacement of recalled products. Consumers possessing an affected vial were instructed to stop using it and discard it.

From a potential litigation perspective, however, a patient who suffered an adverse reaction should consider documenting the product before disposing of it. Photographs showing the vial, pharmacy label, lot number, packaging, prescription information, and other identifying information may become important evidence. A lawyer investigating an injury claim may also advise that potentially relevant physical evidence be preserved rather than destroyed, depending upon the circumstances.

Why Elevated Endotoxin Levels In Injectable Drugs Can Be Dangerous

Endotoxins are associated with the outer membrane of certain bacteria. Their presence can be particularly concerning in products intended to be injected because injection can introduce the material directly into the body rather than exposing it to the protective barriers involved when substances are swallowed.

The FDA has specifically warned about excessive endotoxin exposure from compounded injectable glutathione. According to the agency, symptoms can include fever, chills, muscle pain, headache, nausea, vomiting, hypotension, shock, and death. In its August 27, 2026 safety communication, the FDA reported awareness of at least 30 patients who experienced adverse events after receiving intravenous glutathione alone or in combination with other ingredients. Some cases resulted in hospitalization.

The FDA’s concern regarding glutathione and endotoxins is not entirely new. In an earlier safety communication, the agency described excessive bacterial endotoxin detected in glutathione powder associated with adverse events. The FDA emphasized that ingredients unsuitable for sterile injectable drugs can contain impurities and contaminants capable of harming patients when injected.

The current Centric Compounding recall is therefore particularly important because it concerns injectable products and a contaminant capable of causing rapid systemic reactions.

Nine Adverse Reaction Reports Have Been Associated With The Recalled Products

According to the FDA-posted recall announcement, Centric Compounding received nine reports involving fever, chills, chest pain, nausea or vomiting, headache, and/or malaise.

These reports do not establish that every reported reaction was caused by the recalled products, nor does a recall automatically establish civil liability. Causation must generally be evaluated individually. Nevertheless, adverse event reports can become important during an investigation because attorneys may examine whether multiple patients experienced similar symptoms, whether the symptoms occurred shortly after administration, whether the patients received products from affected lots, and whether alternative explanations exist.

The timing of symptoms can be particularly significant. Medical records may establish when an injection was administered, when symptoms began, what symptoms were reported to healthcare providers, what diagnostic testing was performed, and whether hospitalization or emergency treatment became necessary.

FDA Has Raised Broader Concerns About Glutathione Used In Compounded Injectable Drugs

The Centric Compounding recall occurred against the backdrop of a broader FDA investigation involving injectable glutathione.

On August 27, 2026, the FDA reported that it was aware of at least 30 patients experiencing adverse events following administration of IV glutathione alone or combined with other ingredients. According to the agency, different compounding pharmacies involved had obtained glutathione from Medisca Inc., and the glutathione was labeled dietary supplement grade, which the FDA stated was not appropriate for use as an ingredient in injectable drugs.

The FDA reported symptoms including fever, chills, pain, dizziness, signs of shock, and sepsis-like symptoms, with some patients requiring hospitalization. The agency also stated that it continued receiving adverse event reports consistent with endotoxin exposure and was actively investigating.

Other glutathione recalls involving elevated endotoxin levels have occurred recently as well. In August 2026, the FDA posted recalls from Optimal Balance Pharmacy and Victory Medical Center Pharmacy involving compounded glutathione products and elevated bacterial endotoxin concerns.

These developments may be relevant to lawyers investigating the supply chain and determining where potentially contaminated ingredients originated, which companies handled them, what warnings accompanied the ingredients, and what quality-control procedures were used before finished injectable products reached patients.

What Compensation May Be Available In A Recalled Drug Injury Lawsuit?

A person who establishes that a recalled injectable product caused an injury may potentially seek compensation for losses permitted under applicable state law.

Those damages can include emergency room treatment, ambulance transportation, hospitalization, physician services, diagnostic testing, medication, follow-up care, lost wages, reduced earning capacity, pain and suffering, and other consequences attributable to the injury.

Severe cases involving shock, significant cardiovascular effects, organ injury, prolonged hospitalization, or other lasting complications may produce substantially greater damages than a short-lived reaction.

If an injury results in death, surviving family members or the decedent’s estate may potentially have wrongful death or survival claims. The people legally entitled to bring those claims and the damages available vary considerably among states.

Evidence Can Become Critical In A Centric Compounding Recall Lawsuit

Patients who suffered adverse reactions should try to preserve evidence showing exactly what occurred. This can include medical records, emergency department discharge papers, photographs of the product, prescription documentation, pharmacy communications, receipts, shipping materials, emails concerning the recall, and records identifying the product’s lot number.

A contemporaneous chronology may also help establish when the injection occurred and when symptoms began.

Electronic communications can matter as well. Patients who received emails or text messages notifying them of the recall should preserve them. Records from the prescribing clinic or medical practice may establish when the medication was ordered, where it was obtained, who administered it, and which lot was supplied.

Evidence preservation becomes particularly important when recalled products are being returned, discarded, or replaced. Once physical evidence disappears, reconstructing the precise product and lot involved can become more difficult.

Filing Deadlines Can Differ Depending On Where A Patient Lives And Where The Injury Occurred

Drug injury lawsuits are subject to statutes of limitations. These deadlines vary by state and can depend upon several circumstances, including when the injury occurred, when the patient discovered or reasonably should have discovered a connection between an injury and the product, the identity of the defendants, and the causes of action being asserted.

Patients should not assume that publication of a recall creates a new universal deadline for filing a lawsuit. It generally does not.

An attorney reviewing a potential case should determine which state’s substantive and procedural laws apply and calculate the relevant filing deadlines. Waiting can also create practical evidentiary problems even before a formal statute of limitations expires because records may become harder to obtain, witnesses’ memories can fade, and physical evidence can disappear.

Centric Compounding Recall Lawsuit FAQs

Can I File A Lawsuit If I Became Sick After Receiving A Recalled Centric Compounding Injection?

Potentially. A successful lawsuit would generally require more than proof that you received a recalled product. Attorneys would evaluate whether you received an affected product or lot, whether you experienced an injury, whether medical evidence supports a causal relationship between the injection and your symptoms, and whether a potentially responsible party can be held legally liable.

The FDA-posted announcement confirms that six lots were recalled because the products were compounded using a Glutathione API containing elevated endotoxin levels. The announcement also reports nine adverse reactions. Your medical and pharmacy records can therefore be particularly important in determining whether your circumstances match the recall.

What Symptoms Could Be Associated With Elevated Endotoxin Exposure?

The current recall identifies fever, hypotension, inflammatory reactions, anaphylactic shock, and death as potential significant medical events. Reported adverse reactions associated with the recalled products included fever, chills, chest pain, nausea or vomiting, headache, and malaise.

The FDA’s broader glutathione safety communication also identifies symptoms associated with endotoxin exposure including muscle pain, headache, nausea, vomiting, hypotension, and death. Some patients involved in the broader 2026 glutathione issue experienced shock or sepsis-like symptoms and required hospitalization.

What Should I Do With A Recalled Vial If I Was Injured?

The recall directs consumers to stop using and discard affected vials. However, if you suffered an injury and are considering litigation, you may want to speak with an attorney promptly about evidence preservation before disposing of potentially relevant physical evidence.

At minimum, consider documenting the vial, label, lot number, packaging, prescription information, and any recall communications. An attorney can provide case-specific guidance concerning whether and how physical evidence should be preserved.

Does An FDA Recall Automatically Prove My Lawsuit?

No. A recall can provide important evidence concerning a product safety problem, but it does not automatically establish liability or causation in an individual lawsuit.

A claimant ordinarily must establish the elements required under the applicable state’s law. That may involve demonstrating a defect or negligent act, causation, and legally compensable damages. Medical records, product identification, expert testimony where required, testing information, regulatory records, and evidence concerning the supply chain may all become relevant.

How Long Do I Have To File A Recalled Medication Lawsuit?

There is no single nationwide statute of limitations governing every potential claim involving these recalled products. Deadlines depend upon the applicable state law and facts surrounding the injury.

Because the products were distributed nationwide, different patients may face different deadlines. Determining the applicable limitations period should therefore be part of an early case evaluation rather than something postponed until symptoms or treatment have completely resolved.

Parker Waichman LLP Investigates Centric Compounding Injectable Drug Recall Claims

If you or someone in your family suffered fever, severe chills, chest pain, vomiting, hypotension, an inflammatory reaction, anaphylactic shock, hospitalization, or another serious medical problem after receiving Glutathione, Myer’s Cocktail, Tri-Immune Boost, or another potentially affected compounded glutathione injection, you may have important legal rights.

Parker Waichman LLP is a national personal injury law firm representing people harmed by dangerous and defective products. Our attorneys can investigate the medication you received, identify available pharmacy and medical records, determine whether your product may be associated with an affected lot, evaluate potential defendants, and assess whether you may have grounds to pursue compensation.

There is no charge for a free consultation. Call Parker Waichman LLP at (516) 466-6500 to discuss a potential Centric Compounding recalled injectable drug lawsuit.